AATD

Clinical trials for AATD explained in plain language.

Never miss a new study

Get alerted when new AATD trials appear

Sign up with your email to follow new studies for AATD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

First test of new genetic therapy for rare lung disease

Disease control Ongoing

This is the first human study of an experimental drug called KRRO 110 for Alpha-1 antitrypsin deficiency (AATD), a genetic condition that can cause lung and liver disease. The trial will test single and multiple doses in 64 healthy volunteers and people with AATD to check safety,…

Matched conditions: AATD

Phase: PHASE1, PHASE2 • Sponsor: Korro Bio, Inc. • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

AATD

Get alerted when new AATD trials appear

First test of new genetic therapy for rare lung disease